Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001860782-25-000030
Filing Date
2025-04-28
Accepted
2025-04-28 16:40:37
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A tsvt-20241231.htm   iXBRL 10-K/A 614771
2 EX-31.1 tsvt-fy2410xkaxex311baird1.htm EX-31.1 4115
3 EX-31.2 tsvt-fy2410xkaxex312eatwel.htm EX-31.2 4455
  Complete submission text file 0001860782-25-000030.txt   1247227

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tsvt-20241231.xsd EX-101.SCH 3001
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tsvt-20241231_def.xml EX-101.DEF 3073
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tsvt-20241231_lab.xml EX-101.LAB 137632
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tsvt-20241231_pre.xml EX-101.PRE 73972
20 EXTRACTED XBRL INSTANCE DOCUMENT tsvt-20241231_htm.xml XML 46555
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

EIN.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40791 | Film No.: 25881096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)